SCHEMBL6983033

SCHEMBL6983033

c1cncc(-c2csc3cc(-c4cccs4)ccc23)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.60
CYP3A4 P08684 2/20 0.60
CYP2C9 P11712 2/20 0.60
CYP2E1 P05181 1/20 0.60
CYP2B6 P20813 1/20 0.60
KDM4E B2RXH2 3/20 0.48
HSD17B10 Q99714 3/20 0.48
MAPK1 P28482 1/20 0.48
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.46
RAB9A P51151 1/20 0.46
HDAC3 O15379 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC2 Q92769 2/20 0.44
DYRK1A Q13627 4/20 0.43
DYRK1B Q9Y463 3/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
CASP1 P29466 1/20 0.43
FYN P06241 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6989157 0.99 CYP2A6 (0.59) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
SCHEMBL6985848 0.86 DYRK1A (0.50) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
SCHEMBL6985095 0.83 CYP11B1 (0.45) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
Hydrochloric Acid SCHEMBL6985047 0.82 CYP11B1 (0.44) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
SCHEMBL6987086 0.82 DYRK1A (0.48) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
SCHEMBL6983734 0.82 CYP2A6 (0.59) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
SCHEMBL6985680 0.81 CYP19A1 (0.50) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
Hydrochloric Acid SCHEMBL6981675 0.81 DYRK1A (0.47) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
Hydrochloric Acid SCHEMBL6986441 0.81 CYP2A6 (0.57) CYP2A6CYP3A4CYP2C9CYP2E1CYP2B6
SCHEMBL6981139 0.80 CYP3A4 (0.54) CYP3A4CYP2C9CYP2B6KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130340-A1 Novel benzothiophene derivatives DAIICHI PHARMACEUTICAL CO. LTD. 2003-07-10 US disclosed
EP-1283209-A1 NOVEL BENZOTHIOPHENE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130340-A1 Novel benzothiophene derivatives CYP17A1, CYP21A2, HSD17B1 CYP2A6 110/4885CYP3A4 88/4885CYP2C9 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.